get a key
steadybase-$ company NEPH
account_id none on file
legal_name Nephros Inc
ticker NEPH
cik 1196298
domain nephros.com
entry_point_account_id none on file
name Nephros Inc.
exchange Nasdaq
sector Health Care
hq South Orange, NJ, United States
calls 1 filings 5 executives 14 family 0
why_nownone on file
calls
SD&A expenses decreased by 11% in the nine months of 2024 versus the prior year period due to a decrease in bonus accrual, sales commission expense, stock compensation expense, and travel expenses.

Nov 7, 2024 / receipt, needs a key / Judy Crandall, CFO | earnings call 2024-11-07 | transcript 0fc4e7f2-4a5a-4be9-9004-ef4c0e80fb43 | chars 6817-7014 | segment 7

filings
Continue expansion of sales coverage

ir_statement / Sep 14, 2026 / receipt

Expanding sales team to further capitalize national opportunities

ir_statement / Sep 14, 2026 / receipt

Launch digital tools to support products, customers, and field installations

ir_statement / Sep 14, 2026 / receipt

Achieves profitability and positive adjusted EBITDA for the full year 2024, for the first time in company history.

ir_statement / Sep 14, 2026 / receipt

reduces headcount and other expenses

ir_statement / Sep 14, 2026 / receipt

executives
Alisa Lask director - receipt
Bruce Prashker Interim Chief Financial Officer - receipt
James S. Scibetta Chairman of the Board - receipt
Joseph Harris director - receipt
Judy Crandall CFO - receipt
Judy Krandel Chief Financial Officer - receipt
Judy S. Slotkin director - receipt
Malcom Persen director - receipt
Mark W. Lerner Chief Financial Officer - receipt
Moshe Pinto director - receipt
Oliver Spandow director - receipt
Paul A. Mieyal Acting President - receipt
Robert Banks CEO - receipt
Thomas Gwydir director - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changes
2023-11-06 Chief Financial Officer, appointed sec_8k
2023-11-06 Chief Financial Officer, departed sec_8k
2023-05-11 President and Chief Executive Officer, departed sec_8k
2022-09-08 director, appointed sec_8k
2021-02-03 Chief Financial Officer, appointed sec_8k
2021-02-03 Chief Financial Officer, departed sec_8k
2020-08-14 President and Chief Executive Officer, appointed sec_8k
2020-08-14 President and Chief Executive Officer, departed sec_8k
2019-05-02 director, appointed sec_8k
2019-02-13 director, appointed sec_8k
2018-08-13 director, appointed sec_8k
2017-02-14 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$